قم بالتسجيل لخلق تنبيهات للأدوات الاستثمارية
الأحداث الاقتصادية والمحتوى الخاص بالمؤلفين الذين تتابعهم
تسجيل مجاني هل تملك حساب؟ تسجيل الدخول
اسعار
جميع أنواع الأدوات
- جميع أنواع الأدوات
- مؤشرات
- الأسهم
- الصناديق
- أموال
- سلع
- عملات
- العملات الرقمية
- سندات
- شهادات
برجاء استخدام كلمات أخرى للبحث
🐦 كن أول من ينتهز الخصم.. اكتشف أقوى الأسهم بأقل سعر مع خصم يصل لـ 55% على InvestingPro بالجمعة البيضاء
احصل على الخصم
(0P00000X3M) BlackRock Global Funds - World Healthscience Fund C2
إضافة إلى/حذف من محفظة
أضف محفظة
48.560
+0.040
+0.08%
21/11 - مغلق. العملة ب EUR
النوع:
رأسمال
السوق:
لوكسمبورغ
المُصدر:
BlackRock (Luxembourg) SA
ISIN:
LU0331289677
فئة الاصل:
سهم
- تقييم وكالة (مورننغستار):
- مجموع الأصول: 382.55M
BlackRock Global Funds - World Healthscience Fund
48.560
+0.040
+0.08%
- عام
- الرسم البياني
- تقني
- المنتدى
- نظرة عامة
- بيانات الشركة
- بيانات تاريخية
- الأدوات المملوكة
نظرة عامة - 0P00000X3M
تجد في هذه الصفحة تعريفًا تفصيليًا لـ BlackRock Global Funds - World Healthscience Fund C2. تعرف على أهم أعضاء الكادر الإداري لـ0P00000X3M وإجمالي أصولها واستراتيجيتها الاستثمارية وبيانات الاتصال بها، فضلاً عن معلومات أخرى.
معلومات الإتصال
العنوان
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
الهاتف
+44 20 77433000
الفاكس
Amsterdam
الموقع الإلكتروني
www.blackrock.com
كبار المسؤولين التنفيذيين
| اسم | العنوان | منذ | حتى |
|---|---|---|---|
| Xiang Liu | Director | 2020 | الآن |
| السيرة الذاتية | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | الآن |
| السيرة الذاتية | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| السيرة الذاتية | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| السيرة الذاتية | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
اكتب رأيك عن BlackRock Global Funds - World Healthscience Fund C2
هل أنت واثق من رغبتك في حذف هذا الرسم البياني؟
احذف إلغاء
هل تريد إستبدال الرسم البياني المرفق برسم بياني جديد؟
إستبدال إلغاء
التعليمات لكتابة التعليقات
إضافة رسم بياني إلى تعليق
تأكيد الحظر
هل أنت تريك بالتأكيد الحظر %USER_NAME%؟
إن قيامك بهذا يعني أنك و%USER_NAME% لن تكونا قادرين على رؤية مشاركات الأخرى على Investing.com.
لقد تم إضافة %USER_NAME% بنجاح إلى قائمة الحظر
بما أنك قد قمت برفع الحظر للتو عن هذا الشخص، فإنه يتوجب عليك الإنتظار 48 ساعة قبل أن تتمكن من تجديد الحظر.
قم بالإبلاغ عن هذا التعليق
أخبرنا كيف تشعر حيال هذا التعليق
تم الإبلاغ عن التعليق
شكرا جزيلا
تم إرسال تقريرك إلى مشرفينا لمراجعته